10g of creatine destroyed his deep sleep - Phoenix App Insights

Yes, based on individual tracking data. A Phoenix member noticed that every time he took 10g of creatine daily, his deep sleep dropped by approximately 35 percent and his overall sleep score fell 25 percent. He did not read this in a study or hear it on a podcast, he saw it in his own wearable data tracked over weeks. This is exactly why personal biomarker tracking matters for APOE4 carriers: standard doses that work for general populations can produce outlier effects in specific individuals. The solution is not necessarily to avoid creatine (many carriers tolerate it well at lower doses) but to track your own response rather than assuming study-average effects apply to you.

The Phoenix app launched on iOS as a one-stop health hub for APOE4 carriers running their own Alzheimer's prevention protocol. It combines supplement tracking with community intelligence (see what hundreds of other carriers are taking and their reported outcomes), daily check-ins designed to surface correlations you would not spot on your own, wearable integration with Apple Health and Google Health Connect (Oura, Apple Watch, Whoop), bloodwork tracking with APOE4-specific optimal ranges rather than general-population ranges, and community insights from carriers with matching genetics. Android support is approximately 1-2 weeks away pending Google Play authorization.

Early Phoenix community data reveals several aggregated patterns. Members taking ezetimibe tend to see about 25 percent lower LDL-C on average. Members following a Mediterranean keto approach report roughly 30 percent reduction in ApoB, 23 percent less brain fog, and about 35 percent better cognition scores. Individual outlier findings include a 10g creatine daily dose dropping deep sleep 35 percent in one member, and a 15-minute sunrise walk producing a +2 mood score and noticeable brain fog reduction in another member within 2 weeks. These are community averages and personal case studies, not randomized trial results, but they give APOE4 carriers starting points grounded in carrier-specific biology rather than general population data.

Because standard interventions can produce highly variable effects in APOE4 carriers, and the only way to know what works for YOUR biology is to measure it. Generic protocols and longevity clinics costing $50K per year still cannot tell you what works specifically for APOE4. Tracking your supplements, check-ins, wearables, and bloodwork together lets you surface correlations (sleep quality vs supplement timing, exercise type vs brain fog, mood vs diet changes) that would otherwise stay invisible. Over time, your data starts telling a personal story that is not dependent on generic recommendations from researchers who do not share your genetics.